Showing results (851-860 of 866) with videos related to
Sort By:
Pageof 87
International Heart Journal|May 19, 2020
Prognostic Value of Serum N-Terminal Pro-Brain Natriuretic Peptide Level over Heart Failure for Stroke Events and Deaths in Patients with Atrial FibrillationKeiichiro Kuronuma, Yasuo Okumura, Tomoyuki Morikawa, et al.Heart and Vessels|June 12, 2019
Oral anticoagulant use and clinical outcomes in elderly Japanese patients: findings from the SAKURA AF RegistryToshihiko Nishida, Yasuo Okumura, Katsuaki Yokoyama, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|July 28, 2020
Gastrointestinal Bleeding From Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA Atrial Fibrillation RegistryNobuhiro Murata, Yasuo Okumura, Koichi Nagashima, et al.Current Medical Research and Opinion|July 30, 2019
Adverse clinical events in Japanese atrial fibrillation patients with and without coronary artery disease-findings from the SAKURA AF RegistryDaisuke Fukamachi, Yasuo Okumura, Katsuaki Yokoyama, et al.Journal of Clinical Medicine|February 27, 2020
Impact of the Fibrosis-4 Index on Risk Stratification of Cardiovascular Events and Mortality in Patients with Atrial Fibrillation: Findings from a Japanese Multicenter RegistryYuki Saito, Yasuo Okumura, Koichi Nagashima, et al.Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|July 10, 2015
[Interlaboratory Study on Zinc Test for Food-Contact Rubber Products]Hiroshi Shibata, Motoh Mutsuga, Yutaka Abe, et al.Chemico-Biological Interactions|July 25, 2022
The metabolic and toxic acute effects of phloretin in the rat liverFernanda Sayuri Itou da Silva, Paulo Francisco Veiga Bizerra, Márcio Shigueaki Mito, et al.Scientific Reports|July 16, 2022
Low alanine aminotransferase levels are independently associated with mortality risk in patients with atrial fibrillationYuki Saito, Yasuo Okumura, Koichi Nagashima, et al.Therapeutic Advances in Hematology|July 5, 2022
Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysisYoshiyuki Onda, Junya Kanda, Hitomi Kaneko, et al.Journal of Clinical Medicine|January 16, 2020
Relationship between the Renal Function and Adverse Clinical Events in Patients with Atrial Fibrillation: A Japanese Multicenter Registry SubstudyYasuhumi Yuzawa, Keiichiro Kuronuma, Yasuo Okumura, et al.Pageof 87